Nature Communications (Feb 2019)

PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals

  • Rémi Fromentin,
  • Sandrina DaFonseca,
  • Cecilia T. Costiniuk,
  • Mohamed El-Far,
  • Francesco Andrea Procopio,
  • Frederick M. Hecht,
  • Rebecca Hoh,
  • Steven G. Deeks,
  • Daria J. Hazuda,
  • Sharon R. Lewin,
  • Jean-Pierre Routy,
  • Rafick-Pierre Sékaly,
  • Nicolas Chomont

DOI
https://doi.org/10.1038/s41467-019-08798-7
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 7

Abstract

Read online

The immune checkpoint molecule PD-1 is expressed on a fraction of CD4+ T cells latently infected with HIV, but whether PD-1 plays a functional role in reservoir persistence remains unknown. Here, Fromentin et al. show that PD-1 blockade potentiates latency reversal ex vivo in CD4+ T cells from ART suppressed individuals.